This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carlyle, M. Articles by Hall, J. E. Search for Related Content PubMed PubMed Citation Articles by Carlyle, M. Articles by Hall, J. E. Pubmed/NCBI databases Substance via MeSH Related Collections Obesity Animal models of human disease Other hypertension Energy metabolism Hypertension - basic studies Autonomic, reflex, and neurohumoral control of circulation

(Hypertension. 2002;39:496.)
© 2002 American Heart Association, Inc.

Scientific Contributions

Chronic Cardiovascular and Renal Actions of Leptin

Role of Adrenergic Activity

Megan Carlyle; Oscar B. Jones; Jay J. Kuo; John E. Hall

From the Department of Physiology and Biophysics and Center for Excellence in Cardiovascular-Renal Research, University of Mississippi Medical Center, Jackson, Miss.

Correspondence to Dr John E. Hall, Department of Physiology and Biophysics, University of Mississippi Medical Center, 2500 North State Street, Jackson, MS 39216-4505. E-mail jehall{at}physiology.umsmed.edu

Abstract— This study was designed to determine the role of changes in adrenergic activity in mediating the chronic cardiovascular, renal, and metabolic actions of leptin. Male Sprague-Dawley rats were implanted with catheters for mean arterial pressure (MAP) and heart rate (HR) measurements and IV infusions of either vehicle (n= 7) or - and ß-adrenergic receptor antagonists, terazosin and propranolol (10 mg/kg/d; n= 8) throughout the study. After control measurements, murine leptin was infused IV (1.0 µg/kg/min) for 7 days along with vehicle or adrenergic antagonists, followed by a 7-day recovery period. Leptin infusion significantly reduced food intake in control rats from 22.6±0.8 to 10.6±0.4 g/d and, in adrenergic blockade rats, from 22.6±0.8 to 13.2±0.8 g/d. Fasting plasma insulin decreased from 48±10 to 5±2 µU/mL in control rats and from 51±9 to 9±2 µU/mL in adrenergic blockade rats during leptin infusion. Leptin infusion did not significantly alter glomerular filtration rate in either group. MAP and HR increased by 6±1 mm Hg and 23±7 bpm after 7 days of leptin infusion in control rats. However, in adrenergic blockade rats, leptin infusion did not significantly alter MAP (-1±1 mm Hg) and decreased, rather than increased, HR (-23±8 bpm). These results indicate that leptin-induced increases in blood pressure and tachycardia are mediated by increased adrenergic activity and support the concept that leptin may be an important link between obesity, increased sympathetic activity, and hypertension. However, the chronic effects of leptin on insulin and glucose regulation do not appear to be altered by - and ß-adrenergic receptor blockade.

Key Words: hypertension, obesity • obesity • nervous system, sympathetic • kidney • blood pressure

This article has been cited by other articles:

				A. C. Arnold, H. A. Shaltout, P. E. Gallagher, and D. I. Diz Leptin Impairs Cardiovagal Baroreflex Function at the Level of the Solitary Tract Nucleus Hypertension, November 1, 2009; 54(5): 1001 - 1008. [Abstract] [Full Text] [PDF]

				G. Grassi Assessment of Sympathetic Cardiovascular Drive in Human Hypertension: Achievements and Perspectives Hypertension, October 1, 2009; 54(4): 690 - 697. [Abstract] [Full Text] [PDF]

				H. Bugger and E. D. Abel Rodent models of diabetic cardiomyopathy Dis. Model. Mech., September 1, 2009; 2(9-10): 454 - 466. [Abstract] [Full Text] [PDF]

				E. J. Belin de Chantemele, K. Muta, J. Mintz, M. L. Tremblay, M. B. Marrero, D. J. Fulton, and D. W. Stepp Protein Tyrosine Phosphatase 1B, a Major Regulator of Leptin-Mediated Control of Cardiovascular Function Circulation, September 1, 2009; 120(9): 753 - 763. [Abstract] [Full Text] [PDF]

				A. L. Mark Cardiovascular Side Effects of Antiobesity Drugs: A Yellow Flag in the Race to Safe Pharmacotherapy for Obesity Circulation, September 1, 2009; 120(9): 719 - 721. [Full Text] [PDF]

				A. A. da Silva, J. M. do Carmo, J. N. Freeman, L. S. Tallam, and J. E. Hall A Functional Melanocortin System May Be Required for Chronic CNS-Mediated Antidiabetic and Cardiovascular Actions of Leptin Diabetes, August 1, 2009; 58(8): 1749 - 1756. [Abstract] [Full Text] [PDF]

				J. M. do Carmo, J. E. Hall, and A. A. da Silva Chronic central leptin infusion restores cardiac sympathetic-vagal balance and baroreflex sensitivity in diabetic rats Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H1974 - H1981. [Abstract] [Full Text] [PDF]

				F. Galletti, L. D'Elia, G. Barba, A. Siani, F. P. Cappuccio, E. Farinaro, R. Iacone, O. Russo, D. De Palma, R. Ippolito, et al. High-Circulating Leptin Levels Are Associated with Greater Risk of Hypertension in Men Independently of Body Mass and Insulin Resistance: Results of an Eight-Year Follow-Up Study J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3922 - 3926. [Abstract] [Full Text] [PDF]

				A. A. da Silva, J. M. do Carmo, B. Kanyicska, J. Dubinion, E. Brandon, and J. E. Hall Endogenous Melanocortin System Activity Contributes to the Elevated Arterial Pressure in Spontaneously Hypertensive Rats Hypertension, April 1, 2008; 51(4): 884 - 890. [Abstract] [Full Text] [PDF]

				R. Yang and L. A. Barouch Leptin Signaling and Obesity: Cardiovascular Consequences Circ. Res., September 14, 2007; 101(6): 545 - 559. [Abstract] [Full Text] [PDF]

				K. Rahmouni and D. A. Morgan Hypothalamic Arcuate Nucleus Mediates the Sympathetic and Arterial Pressure Responses to Leptin Hypertension, March 1, 2007; 49(3): 647 - 652. [Abstract] [Full Text] [PDF]

				S. D. Stocker, R. Meador, and J. M. Adams Neurons of the Rostral Ventrolateral Medulla Contribute to Obesity-Induced Hypertension in Rats Hypertension, March 1, 2007; 49(3): 640 - 646. [Abstract] [Full Text] [PDF]

				A. E. Pontiroli, P. Pizzocri, R. Paroni, and F. Folli Sympathetic Overactivity, Endothelial Dysfunction, Inflammation, and Metabolic Abnormalities Cluster in Grade III (World Health Organization) Obesity: Reversal through sustained weight loss obtained with laparoscopic adjustable gastric banding Diabetes Care, December 1, 2006; 29(12): 2735 - 2738. [Full Text] [PDF]

				A. A. da Silva, L. S. Tallam, J. Liu, and J. E. Hall Chronic antidiabetic and cardiovascular actions of leptin: role of CNS and increased adrenergic activity Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1275 - R1282. [Abstract] [Full Text] [PDF]

				L. S. Tallam, A. A. da Silva, and J. E. Hall Melanocortin-4 Receptor Mediates Chronic Cardiovascular and Metabolic Actions of Leptin Hypertension, July 1, 2006; 48(1): 58 - 64. [Abstract] [Full Text] [PDF]

				S. R. Srinivasan, L. Myers, and G. S. Berenson Changes in Metabolic Syndrome Variables Since Childhood in Prehypertensive and Hypertensive Subjects: The Bogalusa Heart Study Hypertension, July 1, 2006; 48(1): 33 - 39. [Abstract] [Full Text] [PDF]

				A. A. da Silva, J. J. Kuo, L. S. Tallam, J. Liu, and J. E. Hall Does Obesity Induce Resistance to the Long-Term Cardiovascular and Metabolic Actions of Melanocortin 3/4 Receptor Activation? Hypertension, February 1, 2006; 47(2): 259 - 264. [Abstract] [Full Text] [PDF]

				W. G Haynes Role of leptin in obesity-related hypertension Exp Physiol, September 1, 2005; 90(5): 683 - 688. [Abstract] [Full Text] [PDF]

				L. S. Tallam, D. E. Stec, M. A. Willis, A. A. da Silva, and J. E. Hall Melanocortin-4 Receptor-Deficient Mice Are Not Hypertensive or Salt-Sensitive Despite Obesity, Hyperinsulinemia, and Hyperleptinemia Hypertension, August 1, 2005; 46(2): 326 - 332. [Abstract] [Full Text] [PDF]

				K. Rahmouni, D. A. Morgan, G. M. Morgan, A. L. Mark, and W. G. Haynes Role of Selective Leptin Resistance in Diet-Induced Obesity Hypertension Diabetes, July 1, 2005; 54(7): 2012 - 2018. [Abstract] [Full Text] [PDF]

				K. Rahmouni, M. L.G. Correia, W. G. Haynes, and A. L. Mark Obesity-Associated Hypertension: New Insights Into Mechanisms Hypertension, January 1, 2005; 45(1): 9 - 14. [Abstract] [Full Text] [PDF]

				L. S. Tallam, J. J. Kuo, A. A. da Silva, and J. E. Hall Cardiovascular, Renal, and Metabolic Responses to Chronic Central Administration of Agouti-Related Peptide Hypertension, December 1, 2004; 44(6): 853 - 858. [Abstract] [Full Text] [PDF]

				A. A. da Silva, J. J. Kuo, and J. E. Hall Role of Hypothalamic Melanocortin 3/4-Receptors in Mediating Chronic Cardiovascular, Renal, and Metabolic Actions of Leptin Hypertension, June 1, 2004; 43(6): 1312 - 1317. [Abstract] [Full Text] [PDF]

				Z.-H. Zhang and R. B. Felder Melanocortin receptors mediate the excitatory effects of blood-borne murine leptin on hypothalamic paraventricular neurons in rat Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2004; 286(2): R303 - R310. [Abstract] [Full Text] [PDF]

				J. J. Kuo, A. A. da Silva, L. S. Tallam, and J. E. Hall Role of Adrenergic Activity in Pressor Responses to Chronic Melanocortin Receptor Activation Hypertension, February 1, 2004; 43(2): 370 - 375. [Abstract] [Full Text] [PDF]

				A. A. da Silva, J. J. Kuo, L. S. Tallam, and J. E. Hall Role of Endothelin-1 in Blood Pressure Regulation in a Rat Model of Visceral Obesity and Hypertension Hypertension, February 1, 2004; 43(2): 383 - 387. [Abstract] [Full Text] [PDF]

				A. Aneja, F. El-Atat, S. I. McFarlane, and J. R. Sowers Hypertension and Obesity Recent Prog. Horm. Res., January 1, 2004; 59(1): 169 - 205. [Abstract] [Full Text]

				K. Rahmouni and W. G. Haynes Leptin and the Cardiovascular System Recent Prog. Horm. Res., January 1, 2004; 59(1): 225 - 244. [Abstract] [Full Text]

				R. Wolk, A. S.M. Shamsuzzaman, and V. K. Somers Obesity, Sleep Apnea, and Hypertension Hypertension, December 1, 2003; 42(6): 1067 - 1074. [Abstract] [Full Text] [PDF]

				J. J. Kuo, O. B. Jones, and J. E. Hall Chronic cardiovascular and renal actions of leptin during hyperinsulinemia Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2003; 284(4): R1037 - R1042. [Abstract] [Full Text] [PDF]

				T. Shirasaka, M. Takasaki, and H. Kannan Cardiovascular effects of leptin and orexins Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2003; 284(3): R639 - R651. [Abstract] [Full Text] [PDF]

				J. E. Hall The Kidney, Hypertension, and Obesity Hypertension, March 1, 2003; 41(3): 625 - 633. [Abstract] [Full Text] [PDF]

				J. J. Kuo, A. A. Silva, and J. E. Hall Hypothalamic Melanocortin Receptors and Chronic Regulation of Arterial Pressure and Renal Function Hypertension, March 1, 2003; 41(3): 768 - 774. [Abstract] [Full Text] [PDF]